{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:12:33Z","timestamp":1784848353790,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP233fa627001"],"award-info":[{"award-number":["JP233fa627001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["223fa627001h0001"],"award-info":[{"award-number":["223fa627001h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22wm0125002, JP223fa627001,"],"award-info":[{"award-number":["JP22wm0125002, JP223fa627001,"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["223fa627001h0001"],"award-info":[{"award-number":["223fa627001h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K20926"],"award-info":[{"award-number":["22K20926"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21K07314"],"award-info":[{"award-number":["21K07314"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21K11592"],"award-info":[{"award-number":["21K11592"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Yamaguchi Education and Scholarship Foundation, Japan"},{"name":"Taiju Life Social Welfare Foundation, Japan"},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJMS2025"],"award-info":[{"award-number":["JPMJMS2025"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["21HB2005"],"award-info":[{"award-number":["21HB2005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People living with HIV (PLWH) with chronic inflammation may have an increasing risk for coronavirus disease 2019 (COVID-19) severity; however, the impact of their gut microbiota on COVID-19 is not fully elucidated. Here, we analyzed the temporal changes in the gut microbiota composition of hospitalized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected PLWH (PLWH-CoV) and their correlation with COVID-19 severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>The 16S rRNA analysis results using stool samples (along the timeline from disease onset) from 12 hospitalized PLWH-CoV, whose median CD4\u2009+\u2009T cell count was 671 cells\/\u00b5l, were compared to those of 19 healthy people and 25 PLWH. Bacterial diversity in PLWH-CoV is not significantly different from that of healthy people and SARS-CoV-2 non-infected PLWH, but a significant difference in the microbiota diversity was observed in the classification according to the disease severity. Immediately after the disease onset, remarkable changes were observed in the gut microbiota of PLWH-CoV, and the changing with a decrease in some short-chain fatty acid-producing bacteria and an increase in colitis-related pathobiont. In the second week after disease onset, relative amounts of specific bacteria distinguished between disease severity. One month after the disease onset, dysbiosis of the gut microbiota persisted, and the number of Enterobacteriaceae, mainly <jats:italic>Escherichia-Shigella<\/jats:italic>, which is potentially pathogenic, increased and were enriched in patients who developed post-acute sequelae of COVID-19 (PASC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The changes in the gut microbiota associated with SARS-CoV-2 infection observed in PLWH in this study indicated a persistent decrease in SCFA-producing bacteria and an intestinal environment with an increase in opportunistic pathogens associated with enteritis. This report demonstrates that the intestinal environment in PLWH tends to show delayed improvement even after COVID-19 recovery, and highlights the importance of the dysbiosis associated with SARS-CoV-2 infection as a potential factor in the COVID-19 severity and the PASC in PLWH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-023-03157-5","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T09:04:32Z","timestamp":1704272672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV"],"prefix":"10.1186","volume":"24","author":[{"given":"Aya","family":"Ishizaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketoshi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Iwatsuki-Horimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"3157_CR1","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.5888\/pcd18.210123","volume":"18","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, Chevinsky JR, Schieber LZ, Summers AD, Lavery AM, et al. Underlying medical conditions and severe Illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66.","journal-title":"Prev Chronic Dis"},{"issue":"11","key":"3157_CR2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120\u20136.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3157_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11904-022-00618-w","volume":"19","author":"MA Spinelli","year":"2022","unstructured":"Spinelli MA, Jones BLH, Gandhi M. COVID-19 outcomes and risk factors among people living with HIV. Curr HIV\/AIDS Rep. 2022;19(5):425\u201332.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"3157_CR4","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/S2352-3018(20)30305-2","volume":"8","author":"K Bhaskaran","year":"2021","unstructured":"Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P, et al. HIV Infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24\u201332.","journal-title":"Lancet HIV"},{"issue":"7","key":"3157_CR5","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1093\/cid\/ciaa1605","volume":"73","author":"AM Geretti","year":"2021","unstructured":"Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, Villa G, Docherty A, Harrison EM, Turtle L, et al. Outcomes of Coronavirus Disease 2019 (COVID-19) related hospitalization among people with Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) clinical characterization protocol (UK): a prospective observational study. Clin Infect Dis. 2021;73(7):e2095-2106.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3157_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0956462420973106","volume":"32","author":"ME Ceballos","year":"2021","unstructured":"Ceballos ME, Ross P, Lasso M, Dominguez I, Puente M, Valenzuela P, Enberg M, Serri M, Munoz R, Pinos Y, et al. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience. Int J STD AIDS. 2021;32(5):435\u201343.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"3157_CR7","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","volume":"9","author":"S Bertagnolio","year":"2022","unstructured":"Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, Haniffa R, Reveiz L, Ford N, Doherty M, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. Lancet HIV. 2022;9(7):e486-495.","journal-title":"Lancet HIV"},{"issue":"2","key":"3157_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/hiv.13174","volume":"23","author":"MJ Lee","year":"2022","unstructured":"Lee MJ, Snell LB, Douthwaite ST, Fidler S, Fitzgerald N, Goodwin L, Hamzah L, Kulasegaram R, Lawrence S, Lwanga J, et al. Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study). HIV Med. 2022;23(2):121\u201333.","journal-title":"HIV Med"},{"issue":"16","key":"3157_CR9","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","volume":"71","author":"N Shalev","year":"2020","unstructured":"Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, Sobieszczyk ME. Clinical characteristics and outcomes in people living with human immunodeficiency virus hospitalized for coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2294\u20137.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3157_CR10","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(20)30164-8","volume":"7","author":"P Vizcarra","year":"2020","unstructured":"Vizcarra P, Perez-Elias MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL, Team CI. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;7(8):e554-564.","journal-title":"Lancet HIV"},{"key":"3157_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijid.2022.05.055","volume":"122","author":"A Bachelard","year":"2022","unstructured":"Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J. Risk factors associated with severe\/critical COVID-19 in people living with HIV-1. Int J Infect Dis. 2022;122:152\u20134.","journal-title":"Int J Infect Dis"},{"key":"3157_CR12","doi-asserted-by":"publisher","first-page":"05036","DOI":"10.7189\/jogh.12.05036","volume":"12","author":"G Favara","year":"2022","unstructured":"Favara G, Barchitta M, Maugeri A, Faro G, Agodi A. HIV Infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.","journal-title":"J Glob Health"},{"issue":"10","key":"3157_CR13","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3201\/eid2710.211461","volume":"27","author":"SA Hoffman","year":"2021","unstructured":"Hoffman SA, Costales C, Sahoo MK, Palanisamy S, Yamamoto F, Huang C, Verghese M, Solis DA, Sibai M, Subramanian A, et al. SARS-CoV-2 neutralization resistance mutations in patient with HIV\/AIDS, California, USA. Emerg Infect Dis. 2021;27(10):2720\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"3157_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40001-022-00824-7","volume":"27","author":"S SeyedAlinaghi","year":"2022","unstructured":"SeyedAlinaghi S, Karimi A, Barzegary A, Mojdeganlou H, Vahedi F, Mirghaderi SP, Shobeiri P, Ramezani M, Yousefi Konjdar P, Mirzapour P, et al. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. Eur J Med Res. 2022;27(1):195.","journal-title":"Eur J Med Res"},{"issue":"2","key":"3157_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/QAD.0000000000003132","volume":"36","author":"J Del Amo","year":"2022","unstructured":"Del Amo J, Polo R, Moreno S, Jarrin I, Hernan MA. SARS-CoV-2 Infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment. AIDS. 2022;36(2):161\u20138.","journal-title":"AIDS"},{"issue":"6","key":"3157_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492\u2013506.","journal-title":"Cell Res"},{"issue":"1","key":"3157_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-023-01445-0","volume":"8","author":"H Seong","year":"2023","unstructured":"Seong H, Choi BK, Han YH, Kim JH, Gim JA, Lim S, Noh JY, Cheong HJ, Kim WJ, Song JY. Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines. Signal Transduct Target Ther. 2023;8(1):178.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3157_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12985-023-02113-z","volume":"20","author":"A Ishizaka","year":"2023","unstructured":"Ishizaka A, Koga M, Mizutani T, Uraki R, Yamayoshi S, Iwatsuki-Horimoto K, Yamamoto S, Imai M, Tsutsumi T, Suzuki Y, et al. Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination. Virol J. 2023;20(1):146.","journal-title":"Virol J"},{"issue":"12","key":"3157_CR19","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV Infection. Nat Med. 2006;12(12):1365\u201371.","journal-title":"Nat Med"},{"issue":"1","key":"3157_CR20","doi-asserted-by":"publisher","first-page":"e0070821","DOI":"10.1128\/Spectrum.00708-21","volume":"9","author":"A Ishizaka","year":"2021","unstructured":"Ishizaka A, Koga M, Mizutani T, Parbie PK, Prawisuda D, Yusa N, Sedohara A, Kikuchi T, Ikeuchi K, Adachi E, et al. Unique gut microbiome in HIV patients on antiretroviral therapy (ART) suggests association with chronic inflammation. Microbiol Spectr. 2021;9(1):e0070821.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"3157_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/v14050950","volume":"14","author":"T Mizutani","year":"2022","unstructured":"Mizutani T, Ishizaka A, Koga M, Tsutsumi T, Yotsuyanagi H. Role of microbiota in viral infections and pathological progression. Viruses. 2022;14(5):950.","journal-title":"Viruses"},{"issue":"1","key":"3157_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12866-020-02074-1","volume":"21","author":"Y Xie","year":"2021","unstructured":"Xie Y, Sun J, Wei L, Jiang H, Hu C, Yang J, Huang Y, Ruan B, Zhu B. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals. BMC Microbiol. 2021;21(1):11.","journal-title":"BMC Microbiol"},{"issue":"15","key":"3157_CR23","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.cell.2021.05.023","volume":"184","author":"K Nganou-Makamdop","year":"2021","unstructured":"Nganou-Makamdop K, Talla A, Sharma AA, Darko S, Ransier A, Laboune F, Chipman JG, Beilman GJ, Hoskuldsson T, Fourati S, et al. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell. 2021;184(15):3899-3914 e3816.","journal-title":"Cell"},{"issue":"1","key":"3157_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40168-018-0580-7","volume":"6","author":"AJS Armstrong","year":"2018","unstructured":"Armstrong AJS, Shaffer M, Nusbacher NM, Griesmer C, Fiorillo S, Schneider JM, Preston Neff C, Li SX, Fontenot AP, Campbell T, et al. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome. 2018;6(1):198.","journal-title":"Microbiome"},{"issue":"4","key":"3157_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/mi.2016.97","volume":"10","author":"CF Kelley","year":"2017","unstructured":"Kelley CF, Kraft CS, de Man TJ, Duphare C, Lee HW, Yang J, Easley KA, Tharp GK, Mulligan MJ, Sullivan PS, et al. The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention. Mucosal Immunol. 2017;10(4):996\u20131007.","journal-title":"Mucosal Immunol"},{"key":"3157_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian M, Rocafort M, Guillen Y, Rivera J, Casadella M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine. 2016;5:135\u201346.","journal-title":"EBioMedicine"},{"issue":"1","key":"3157_CR27","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-020-16222-8","volume":"11","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sortino O, Verheij E, Sklar J, Wit FW, Kootstra NA, Sellers B, Brenchley JM, Ananworanich J, Loeff MSV, et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat Commun. 2020;11(1):2448.","journal-title":"Nat Commun"},{"key":"3157_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ebiom.2019.07.027","volume":"46","author":"J Alzahrani","year":"2019","unstructured":"Alzahrani J, Hussain T, Simar D, Palchaudhuri R, Abdel-Mohsen M, Crowe SM, Mbogo GW, Palmer CS. Inflammatory and immunometabolic consequences of gut dysfunction in HIV: parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities. EBioMedicine. 2019;46:522\u201331.","journal-title":"EBioMedicine"},{"issue":"10","key":"3157_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/v13102101","volume":"13","author":"A Ishizaka","year":"2021","unstructured":"Ishizaka A, Koga M, Mizutani T, Lim LA, Adachi E, Ikeuchi K, Ueda R, Aoyagi H, Tanaka S, Kiyono H, et al. Prolonged gut dysbiosis and fecal excretion of hepatitis a virus in patients infected with human immunodeficiency virus. Viruses. 2021;13(10):2101.","journal-title":"Viruses"},{"key":"3157_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13098-018-0312-y","volume":"10","author":"DD Bosho","year":"2018","unstructured":"Bosho DD, Dube L, Mega TA, Adare DA, Tesfaye MG, Eshetie TC. Prevalence and predictors of metabolic syndrome among people living with human immunodeficiency virus (PLWHIV). Diabetol Metab Syndr. 2018;10:10.","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"3157_CR31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/infdis\/jit025","volume":"207","author":"G Mendez-Lagares","year":"2013","unstructured":"Mendez-Lagares G, Romero-Sanchez MC, Ruiz-Mateos E, Genebat M, Ferrando-Martinez S, Munoz-Fernandez MA, Pacheco YM, Leal M. Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14. J Infect Dis. 2013;207(8):1221\u20135.","journal-title":"J Infect Dis"},{"issue":"2","key":"3157_CR32","doi-asserted-by":"publisher","first-page":"e0168921","DOI":"10.1128\/spectrum.01689-21","volume":"10","author":"T Mizutani","year":"2022","unstructured":"Mizutani T, Ishizaka A, Koga M, Ikeuchi K, Saito M, Adachi E, Yamayoshi S, Iwatsuki-Horimoto K, Yasuhara A, Kiyono H, et al. Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization. Microbiol Spectr. 2022;10(2):e0168921.","journal-title":"Microbiol Spectr"},{"issue":"4","key":"3157_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698\u2013706.","journal-title":"Gut"},{"issue":"3","key":"3157_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71(3):544\u201352.","journal-title":"Gut"},{"key":"3157_CR35","doi-asserted-by":"publisher","first-page":"175628482211184","DOI":"10.1177\/17562848221118403","volume":"15","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, Sharma V. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2022;15:17562848221118404.","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"3157_CR36","doi-asserted-by":"publisher","first-page":"19417","DOI":"10.1038\/s41598-020-76474-8","volume":"10","author":"MH Kim","year":"2020","unstructured":"Kim MH, Yun KE, Kim J, Park E, Chang Y, Ryu S, Kim HL, Kim HN. Gut microbiota and metabolic health among overweight and obese individuals. Sci Rep. 2020;10(1):19417.","journal-title":"Sci Rep"},{"key":"3157_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.","journal-title":"Front Immunol"},{"issue":"3","key":"3157_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/v14030493","volume":"14","author":"M Mazzitelli","year":"2022","unstructured":"Mazzitelli M, Trunfio M, Sasset L, Leoni D, Castelli E, Lo Menzo S, Gardin S, Putaggio C, Brundu M, Garzotto P, et al. Factors associated with severe COVID-19 and post-acute COVID-19 syndrome in a cohort of people living with HIV on antiretroviral treatment and with undetectable HIV RNA. Viruses. 2022;14(3):493.","journal-title":"Viruses"},{"issue":"10","key":"3157_CR39","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/cid\/ciaa709","volume":"71","author":"S Gu","year":"2020","unstructured":"Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020;71(10):2669\u201378.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3157_CR40","first-page":"276","volume":"70","author":"T Zuo","year":"2021","unstructured":"Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70(2):276\u201384.","journal-title":"Gut"},{"issue":"12","key":"3157_CR41","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1097\/MIB.0000000000000972","volume":"22","author":"K Takeshita","year":"2016","unstructured":"Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, et al. A single species of Clostridium Subcluster XIVa decreased in ulcerative colitis patients. Inflamm Bowel Dis. 2016;22(12):2802\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3157_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17(5):505\u201313.","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"3157_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156(1\u20132):84\u201396.","journal-title":"Cell"},{"issue":"7480","key":"3157_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451\u20135.","journal-title":"Nature"},{"issue":"7480","key":"3157_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350.","journal-title":"Nature"},{"issue":"1","key":"3157_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chom.2021.11.001","volume":"30","author":"M Alexander","year":"2022","unstructured":"Alexander M, Ang QY, Nayak RR, Bustion AE, Sandy M, Zhang B, Upadhyay V, Pollard KS, Lynch SV, Turnbaugh PJ. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe. 2022;30(1):17-30 e19.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3157_CR47","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1128\/JCM.02926-14","volume":"53","author":"BJ Gardiner","year":"2015","unstructured":"Gardiner BJ, Tai AY, Kotsanas D, Francis MJ, Roberts SA, Ballard SA, Junckerstorff RK, Korman TM. Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J Clin Microbiol. 2015;53(2):626\u201335.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"3157_CR48","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1038\/s41467-022-34260-2","volume":"13","author":"MR Stutz","year":"2022","unstructured":"Stutz MR, Dylla NP, Pearson SD, Lecompte-Osorio P, Nayak R, Khalid M, Adler E, Boissiere J, Lin H, Leiter W, et al. Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022;13(1):6615.","journal-title":"Nat Commun"},{"key":"3157_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-49688-7_4","volume-title":"New insights on antiviral probiotics: from research to applications","author":"I Al Kassaa","year":"2017","unstructured":"Al Kassaa I. The antiviral activity of probiotic metabolites. In: New insights on antiviral probiotics: from research to applications. 2017. p. 83\u201397."},{"issue":"1","key":"3157_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.gtc.2010.12.009","volume":"40","author":"EM Quigley","year":"2011","unstructured":"Quigley EM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin. 2011;40(1):207\u201322.","journal-title":"Gastroenterol Clin"},{"issue":"1","key":"3157_CR51","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, Sun J, Pan F, Zhou J, Zhang W, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457.","journal-title":"Nat Commun"},{"issue":"10","key":"3157_CR52","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI72330","volume":"124","author":"SR Dalal","year":"2014","unstructured":"Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190\u20136.","journal-title":"J Clin Invest"},{"issue":"1","key":"3157_CR53","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1038\/s41598-020-59937-w","volume":"10","author":"Y Sekido","year":"2020","unstructured":"Sekido Y, Nishimura J, Nakano K, Osu T, Chow CT, Matsuno H, Ogino T, Fujino S, Miyoshi N, Takahashi H, et al. Some Gammaproteobacteria are enriched within CD14(+) macrophages from intestinal lamina propria of Crohn\u2019s disease patients versus mucus. Sci Rep. 2020;10(1):2988.","journal-title":"Sci Rep"},{"key":"3157_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","volume":"49","author":"A Cattaneo","year":"2017","unstructured":"Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60\u20138.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"3157_CR55","doi-asserted-by":"publisher","first-page":"e0192622","DOI":"10.1128\/spectrum.01926-22","volume":"10","author":"S Li","year":"2022","unstructured":"Li S, Guo J, Liu R, Zhang F, Wen S, Liu Y, Ren W, Zhang X, Shang Y, Gao M, et al. Predominance of Escherichia-Shigella in gut microbiome and its potential correlation with elevated level of plasma tumor necrosis factor alpha in patients with tuberculous meningitis. Microbiol Spectr. 2022;10(6):e0192622.","journal-title":"Microbiol Spectr"},{"key":"3157_CR56","doi-asserted-by":"publisher","first-page":"e2250163","DOI":"10.1002\/eji.202250163","volume":"53","author":"JJ Taitz","year":"2023","unstructured":"Taitz JJ, Tan JK, Potier-Villette C, Ni D, King NJ, Nanan R, Macia L. Diet, commensal microbiota-derived extracellular vesicles, and host immunity. Eur J Immunol. 2023;53:e2250163.","journal-title":"Eur J Immunol."},{"issue":"4","key":"3157_CR57","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s40121-022-00654-4","volume":"11","author":"P Villoslada-Blanco","year":"2022","unstructured":"Villoslada-Blanco P, Perez-Matute P, Iniguez M, Recio-Fernandez E, Blanco-Navarrete P, Metola L, Ibarra V, Alba J, de Toro M, Oteo JA. Integrase inhibitors partially restore bacterial translocation, inflammation and gut permeability induced by HIV infection: impact on gut microbiota. Infect Dis Ther. 2022;11(4):1541\u201357.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"3157_CR58","doi-asserted-by":"publisher","first-page":"21526","DOI":"10.7448\/IAS.20.1.21526","volume":"20","author":"MJ Villanueva-Millan","year":"2017","unstructured":"Villanueva-Millan MJ, Perez-Matute P, Recio-Fernandez E, Lezana Rosales JM, Oteo JA. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. J Int AIDS Soc. 2017;20(1):21526.","journal-title":"J Int AIDS Soc"},{"issue":"18","key":"3157_CR59","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"RT Gandhi","year":"2020","unstructured":"Gandhi RT, Lynch JB, Del Rio C. Mild or moderate covid-19. N Engl J Med. 2020;383(18):1757\u201366.","journal-title":"N Engl J Med"},{"issue":"1","key":"3157_CR60","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, Glockner FO. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3157_CR61","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"3157_CR62","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"Database issue","key":"3157_CR63","first-page":"D590","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590-596.","journal-title":"Nucleic Acids Res"},{"key":"3157_CR64","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, M\u00fcller A, Nothman J, Louppe G, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay \u00c9. Scikit-learn: machine learning in python. JMLR. 2011;12:2825\u201330.","journal-title":"JMLR"},{"key":"3157_CR65","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3389\/fmicb.2017.02114","volume":"8","author":"A Kaul","year":"2017","unstructured":"Kaul A, Mandal S, Davidov O, Peddada SD. Analysis of microbiome data in the presence of excess zeros. Front Microbiol. 2017;8:2114.","journal-title":"Front Microbiol"},{"issue":"6","key":"3157_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"3157_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3157_CR68","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.","journal-title":"Genome Biol"},{"issue":"11","key":"3157_CR69","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EH, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.","journal-title":"PLoS Comput Biol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-03157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-03157-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-03157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T09:06:09Z","timestamp":1704272769000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-03157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-03157-5","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Institute of Medical Science, University of Tokyo (IMSUT; approval number: (reference 28-55-0330, 2019-71-0201). All methods were performed by the relevant guidelines and regulations. This study was conducted by the Declaration of Helsinki and written informed consent for sample collection and subsequent analysis was provided by all participants before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toya-ma Chemical, Tauns Laboratories, Inc., Shionogi &#x0026; Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio and is a co-founder of FluGen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}